NCT03266848View on ClinicalTrials.gov

Quantitative Non-Invasive Brain Imaging Using QUTE-CE MRI

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

November 8, 2017

Primary Completion Date

July 22, 2020

Study Completion Date

July 22, 2020

Conditions
Cerebrovascular Disorders
Interventions
DIAGNOSTIC_TEST

Quantitative Magnetic Resonance Imaging

Radiological diagnosis

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

collaborator

Northeastern University

OTHER

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Theranano LLC

INDUSTRY

NCT03266848 - Quantitative Non-Invasive Brain Imaging Using QUTE-CE MRI | Biotech Hunter | Biotech Hunter